Anti-SEMG1/ CT103/ SEMG functional antibody

Anti-SEMG1/ CT103/ SEMG functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to SEMG1/SEMG1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1275-Ab-1/ GM-Tg-hg-SE1275-Ab-2Anti-Human SEMG1 monoclonal antibodyHuman
GM-Tg-rg-SE1275-Ab-1/ GM-Tg-rg-SE1275-Ab-2Anti-Rat SEMG1 monoclonal antibodyRat
GM-Tg-mg-SE1275-Ab-1/ GM-Tg-mg-SE1275-Ab-2Anti-Mouse SEMG1 monoclonal antibodyMouse
GM-Tg-cynog-SE1275-Ab-1/ GM-Tg-cynog-SE1275-Ab-2Anti-Cynomolgus/ Rhesus macaque SEMG1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1275-Ab-1/ GM-Tg-felg-SE1275-Ab-2Anti-Feline SEMG1 monoclonal antibodyFeline
GM-Tg-cang-SE1275-Ab-1/ GM-Tg-cang-SE1275-Ab-2Anti-Canine SEMG1 monoclonal antibodyCanine
GM-Tg-bovg-SE1275-Ab-1/ GM-Tg-bovg-SE1275-Ab-2Anti-Bovine SEMG1 monoclonal antibodyBovine
GM-Tg-equg-SE1275-Ab-1/ GM-Tg-equg-SE1275-Ab-2Anti-Equine SEMG1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1275-Ab-1/ GM-Tg-hg-SE1275-Ab-2; GM-Tg-rg-SE1275-Ab-1/ GM-Tg-rg-SE1275-Ab-2;
GM-Tg-mg-SE1275-Ab-1/ GM-Tg-mg-SE1275-Ab-2; GM-Tg-cynog-SE1275-Ab-1/ GM-Tg-cynog-SE1275-Ab-2;
GM-Tg-felg-SE1275-Ab-1/ GM-Tg-felg-SE1275-Ab-2; GM-Tg-cang-SE1275-Ab-1/ GM-Tg-cang-SE1275-Ab-2;
GM-Tg-bovg-SE1275-Ab-1/ GM-Tg-bovg-SE1275-Ab-2; GM-Tg-equg-SE1275-Ab-1/ GM-Tg-equg-SE1275-Ab-2
Products NameAnti-SEMG1 monoclonal antibody
Formatmab
Target NameSEMG1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SEMG1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1275-Ag-1Recombinant multi-species SEMG1/ CT103/ SEMG protein


    Target information

    Target IDGM-SE1275
    Target NameSEMG1
    Gene ID6406
    Gene Symbol and SynonymsCT103,dJ172H20.2,SEMG,SEMG1,SGI
    Uniprot AccessionP04279
    Uniprot Entry NameSEMG1_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseContrast - Induced Nephropathy, Malignant neoplasm of bladder
    Gene EnsemblENSG00000124233
    Target ClassificationN/A

    The target: SEMG1, gene name: SEMG1, also named as CT103, SEMG, SGI, dJ172H20.2. The protein encoded by this gene is the predominant protein in semen. The encoded secreted protein is involved in the formation of a gel matrix that encases ejaculated spermatozoa. This preproprotein is proteolytically processed by the prostate-specific antigen (PSA) protease to generate multiple peptide products that exhibit distinct functions. One of these peptides, SgI-29, is an antimicrobial peptide with antibacterial activity. This proteolysis process also breaks down the gel matrix and allows the spermatozoa to move more freely. This gene and another similar semenogelin gene are present in a gene cluster on chromosome 20. [provided by RefSeq, Feb 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.